Unclassifiable parkinsonism in two European tertiary referral centres for movement disorders

Movement Disorders

Volumn 18, Issue 10, 2003, Pages 1123-1131

  Katzenschlager, Regina ^a   Cardozo, Adriana ^b   Cobo, M Rosario Avila ^b   Tolosa, Eduardo ^b   Lees, Andrew J ^a,c  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Atypical parkinsonism; Clinical diagnostic criteria

Indexed keywords

BENSERAZIDE; LEVODOPA; NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; DRUG RESPONSE; DYSTONIA; EUROPE; FACE DISORDER; FEMALE; FOLLOW UP; HALLUCINATION; HEALTH CARE FACILITY; HEALTH SURVEY; HUMAN; INDIGESTION; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MENTAL DISEASE; MOTOR DYSFUNCTION; NAUSEA; NEUROLOGIC DISEASE; NEUROPATHOLOGY; OUTPATIENT DEPARTMENT; PARKINSON DISEASE; PARKINSONISM; PATIENT REFERRAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPAIN; TREATMENT FAILURE; TREMOR; UNITED KINGDOM; VERTIGO; WESTERN EUROPE;

AGE OF ONSET; AGED; AGED, 80 AND OVER; ANTIPARKINSON AGENTS; CROSS-SECTIONAL STUDIES; DEMOGRAPHY; DIAGNOSIS, DIFFERENTIAL; ETHNIC GROUPS; EUROPE; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; MOVEMENT DISORDERS; NEUROLOGIC EXAMINATION; OUTPATIENT CLINICS, HOSPITAL; PARKINSONIAN DISORDERS; PREVALENCE; PROSPECTIVE STUDIES; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 0141612292     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.10523     Document Type: Article

References (41)

1. Gibb WRG, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:745-752.
2. Elizan TS, Hirano A, Abrams BM. Amyotrophic lateral sclerosis and parkinsonism-dementia complex on Guam: neurological re-evaluation. Arch Neurol 1966;14:356-368.
3. Spencer PS, Kisby GE, Ludolph AC. Slow toxins, biologic markers, and long-latency neurodegenerative disease in the Western Pacific region. Neurology 1991;41(Suppl. 2):62-66.
4. Araki S, Iwahashi Y, Kuroiwa Y. Epidemiological study of amyotrophic lateral sclerosis and allied disorders in the Kii Peninsula (Japan). J Neurol Sci 1967;4:279-287.
5. Chaudhuri K, Hu MTM, Brooks DJ. Atypical parkinsonism in Afro-Caribbean and Indian origin immigrants to the UK [review]. Mov Disord 2000;15:18-23.
6. Caparros-Lefebvre D, Elbaz A, and the Caribbean Parkinsonism Study Group. Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case-control study. Lancet 1999;354:281-286.
7. Caparros-Lefebvre D, Sergeant N, Lees A, et al. Guadeloupan parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy. Brain 2002;125:801-811.
8. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
9. Rajput AH, Rodzilsky B, Rajput A. Accuracy of clinical diagnosis in parkinsonism: a prospective study. Can J Neurol Sci 1991;18: 275-278.
10. Hughes AJ, Daniel SE, Lees AJ. Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology 2001;57: 1497-1499.
11. Gilman S, Low PA, Quinn N, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 1999;163:94-98.
12. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP International Workshop. Neurology 1996;47:1-9.
13. Tolosa E, Valldeoriola F, Cruz-Sanchez F. Progressive supranuclear palsy: clinical and pathological diagnosis. Eur J Neurol 1995;2:259-273.
14. Lang AE, Riley DE, Bergeron C. Cortico-basal ganglionic degeneration. In: Calne DB, editor. Neurodegenerative diseases. Philadelphia: WB Saunders; 1994. p 877-894.
15. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113-1124.
16. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
17. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration. A consensus on clinical diagnostic criteria. Neurology 1998;51:1546-1554.
18. WHO. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical descriptions and diagnostic guidelines. F02.0 Dementia in Pick's disease. Geneva: World Health Organization; 1992
19. Winikates J, Jankovic J. Clinical correlates of vascular parkinsonism. Arch Neurol 1999;56:98-102.
20. Zijlmans JCM, Thijssen HOM, Vogels OJM, et al. MRI in patients suspected of vascular parkinsonism. Neurology 1995;45:2183-2188.
21. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
22. Doty RL, Shaman P, Dann M. Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiol Behav 1984;32:489-502.
23. Fahn S, Elton RL, and the members of the UPDRS Development Committee. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Caine DB, editors. Recent developments in Parkinson's disease. London: MacMillan; 1987. p 153-163.
24. Albanese A, Bonuccelli U, Brefel C, et al. Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease. Mov Disord 2001;16:197-201.
25. Jankovic J, Rajput AH, McDermott MP, Perl DP, for the Parkinson Study Group. The evolution of diagnosis in early Parkinsons disease. Arch Neurol 2000;57:369-372.
26. Parkinson Study Group. Effect of deprenyl on the progression of disability in early Parkinson's disease. N Engl J Med 1989;321: 1364-1371.
27. Grimes DA, Lang AE, Bergeron CB. Dementia as the most common presentation of cortico-basal ganglionic degeneration. Neurology 1999;53:1969-1974.
28. Rajput AH, Rodzilsky B, Rajput A, Ang L. Levodopa efficacy and pathological basis of Parkinson syndrome. Clin Neuropharmacol 1990;13:553-558.
29. Sage JI, Miller DC, Golbe LI, Walters A, Duvoisin R. Clinically atypical expression of pathologically typical Lewy-body parkinsonism. Clin Neuropharmacol 1990;13:36-47.
30. Mark MH, Sage JI, Dickson DW, Schwarz KO, Duvoisin RC. Levodopa-nonresponsive Lewy body parkinsonism: clinicopathologic study of two cases. Neurology 1992;42:1323-1327.
31. Hughes AJ, Daniel SE, Blankson S, Lees AJ. A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 1993;50: 140-148.
32. Calne DB, Snow BJ, Lee C. Criteria for diagnosing Parkinson's disease. Ann Neurol 1992;32(Suppl.):S125-127.
33. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson's disease. Arch Neurol 1999;56:33-39.
34. Ward CD, Gibb WR. Research diagnostic criteria for Parkinson's disease. In: Streifler MB, Korczyn AD, Melamed E, Youdim MBH, editors. Advances in neurology. Vol. 53. Parkinson's disease: anatomy, pathology, and therapy. New York: Raven Press; 1990.
35. Larsen JP, Dupont E, Tandberg E. Clinical diagnosis of Parkinson's disease. Proposal of diagnostic subgroups classified at different levels of confidence. Acta Neurol Scand 1994;89:242-251.
36. Hughes AJ, Lees AJ, Stern GM. Challenge tests to predict the dopaminergic response in untreated PD. Neurology 1991;41:1723-1725.
37. Krauss JK, Regel JP, Droste DW, Orszagh M, Borremans JJ, Vach W. Movement disorders in adult hydrocephalus. Mov Disord 1997; 12:53-60.
38. Curran T, Lang AE. Parkinsonian syndromes associated with hydrocephalus: case reports, a review of the literature, and pathophysiological hypotheses. Mov Disord 1994;9:508-520.
39. Reuter I, Hu MTM, Andrews TC, Brooks DJ, Clough C, Ray Chaudhuri K. Late onset levodopa responsive Huntington's disease with minimal chorea masquerading as Parkinson plus syndrome. J Neurol Neurosurg Psychiatry 2000;68:238-241.
40. Hu MTM. Cortical and striatal function in a cross-racial Parkinson's disease population [doctoral thesis]. Chap. 6. University of London; 2001. p 135-164.
41. Wenning GK, Shephard B, Hawkes C, Petruckevitch A, Lees A, Quinn N. Olfactory function in atypical parkinsonian syndromes. Acta Neurol Scand 1995;91:247-250.